Biosensors International Group, Ltd. (“Biosensors” or the “Company”, Bloomberg: BIG:SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices for interventional cardiology and critical care procedures, today announced it will be participating in the 30th Annual J.P. Morgan Healthcare Conference which will be held from 9th to 12th January 2012 in San Francisco, United States.
During this conference, the senior management of Biosensors will present on Thursday, January 12th, 2012 at 11:00am PST within the Asia Healthcare Company Track, and will also meet investors in scheduled one-on-one and small group meetings throughout the conference.
Portfolio Performance – Jan 2025
-
Market Performance Amid Trade Tensions Despite ongoing trade concerns, the
S&P 500 rose by 2.7%, the Nasdaq by 1.7%, and the Dow by 4.7%, showing
cautiou...
7 hours ago
No comments:
Post a Comment